Beta-alanine High Intensity Exercise Meta-analysis: What the Evidence Says

Beta-alanine High Intensity Exercise Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this fir

3 min read · 589 wordsReviewed June 2026
Athletes engaging in an intense Crossfit workout utilizing plyo boxes for strength building indoors. - Evidence evidence guide for beta-alanine high intensity exercise meta-analysis
Photo by cottonbro studio on Pexels · Pexels License

Quick Answer

Beta alanine High Intensity Exercise Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 2 systematic review.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Beta-alanine High Intensity Exercise Meta-analysis: What the Evidence Says

Quick Answer

Beta-alanine High Intensity Exercise Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 2 systematic review.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
The impact of long-term exercise on liver function, fatty liver progression, and related metabolic markers in NAFLD patients: a meta-analysis of randomized controlled trials systematic review 1 2026-03-30 10.3389/fnut.2026.1731510
No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials systematic review 1 2026-03-26 10.3389/fnut.2026.1818755

What The Sources Report

  • Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and has become an important risk factor for liver cirrhosis, liver cancer, and cardiovascular diseases. [Guo Yongqing (2026); evidence level 1]
  • As a result, lifestyle interventions, particularly exercise, have gained increasing attention as a potential therapeutic strategy for NAFLD patients. [Guo Yongqing (2026); evidence level 1]
  • Importantly, mechanistic evidence indicates that performance loss during repeated maximal efforts reflects an integrated disturbance in muscle function-encompassing substrate availability, metabolite/ionic perturbations, excitation-contraction coupling, and only later, more pronounced acid-base disruption-rather than a single dominant metabolite (-). [Liang Weibao (2026); evidence level 1]
  • Consistent with this mechanism, contemporary meta-analytic evidence indicates the most reproducible ergogenic effects in high-intensity exercise tasks of approximately 1-4 min, where acid-base perturbation is more likely to be performance-limiting. [Liang Weibao (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For beta-alanine high intensity exercise meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Guo Yongqing (2026). The impact of long-term exercise on liver function, fatty liver progression, and related metabolic markers in NAFLD patients: a meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1731510. PMCID: PMC13070912. PMID: 41983068. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13070912/
  • Liang Weibao (2026). No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1818755. PMCID: PMC13061858. PMID: 41971372. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13061858/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed June 9, 2026 by Migaku Evidence Review

← All GuidesSupplement Reference →